Research Analysts’ Weekly Ratings Updates for CME Group (CME)

Several analysts have recently updated their ratings and price targets for CME Group (NASDAQ: CME):

• 1/6/2026 – CME Group had its “neutral” rating reaffirmed by analysts at UBS Group AG.
• 1/5/2026 – CME Group had its price target raised by analysts at Raymond James Financial, Inc. from $307.00 to $311.00. They now have an “outperform” rating on the stock.
• 12/29/2025 – CME Group had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – CME Group had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – CME Group had its price target raised by analysts at Morgan Stanley from $314.00 to $320.00. They now have an “overweight” rating on the stock.
• 12/17/2025 – CME Group had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $310.00 to $318.00. They now have a “buy” rating on the stock.
• 12/12/2025 – CME Group had its price target raised by analysts at Barclays PLC from $280.00 to $304.00. They now have an “equal weight” rating on the stock.
• 12/10/2025 – CME Group had its price target raised by analysts at Bank of America Corporation from $201.00 to $209.00.
• 12/5/2025 – CME Group had its price target raised by analysts at Royal Bank Of Canada from $282.00 to $295.00. They now have a “sector perform” rating on the stock.
• 12/4/2025 – CME Group had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a “sell” rating on the stock.
• 11/25/2025 – CME Group had its price target raised by analysts at The Goldman Sachs Group, Inc. from $263.00 to $264.00. They now have a “sell” rating on the stock.
• 11/14/2025 – CME Group had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00. They now have a “buy” rating on the stock.
• 11/13/2025 – CME Group had its price target raised by analysts at Piper Sandler from $296.00 to $313.00. They now have an “overweight” rating on the stock.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is currently 48.45%.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 251 shares of the business’s stock in a transaction dated Tuesday, December 30th. The stock was bought at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the acquisition, the director directly owned 258,710 shares in the company, valued at $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director owned 1,091 shares in the company, valued at approximately $287,511.23. The trade was a 47.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.